Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

ClinicalTrials.gov ID: NCT00150384

Public ClinicalTrials.gov record NCT00150384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Utility Of Caduet In Simultaneously Achieving Blood Pressure And Lipid Endpoints In A Specific Patient Population (CAPABLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Study identification

NCT ID
NCT00150384
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Not listed
Completion
Aug 2005 (Actual)
Last update posted
Jan 27, 2021

2004 – 2005

United States locations

U.S. sites
106
U.S. states
26
U.S. cities
76
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35209 —
Pfizer Investigational Site Birmingham Alabama 35211 —
Pfizer Investigational Site Huntsville Alabama 35801 —
Pfizer Investigational Site Little Rock Arkansas 72204 —
Pfizer Investigational Site Los Angeles California 90024 —
Pfizer Investigational Site Oakland California 94609-3425 —
Pfizer Investigational Site Pico Rivera California 90660 —
Pfizer Investigational Site Bridgeport Connecticut 6610 —
Pfizer Investigational Site Washington D.C. District of Columbia 20010 —
Pfizer Investigational Site Washington D.C. District of Columbia 20037 —
Pfizer Investigational Site Aventura Florida 33180 —
Pfizer Investigational Site Gainesville Florida 32601 —
Pfizer Investigational Site Jacksonville Florida 32204 —
Pfizer Investigational Site Orlando Florida 32806 —
Pfizer Investigational Site Pensacola Florida 32503 —
Pfizer Investigational Site Vero Beach Florida 32960 —
Pfizer Investigational Site Athens Georgia 30606 —
Pfizer Investigational Site Atlanta Georgia 30303 —
Pfizer Investigational Site Atlanta Georgia 30309 —
Pfizer Investigational Site Atlanta Georgia 30310 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Augusta Georgia 30904 —
Pfizer Investigational Site Columbus Georgia 31901 —
Pfizer Investigational Site Columbus Georgia 31904 —
Pfizer Investigational Site Decatur Georgia 30033 —
Pfizer Investigational Site Lincolnton Georgia 30817 —
Pfizer Investigational Site Savannah Georgia 31406 —
Pfizer Investigational Site Chicago Illinois 60616 —
Pfizer Investigational Site Chicago Illinois 60637-1470 —
Pfizer Investigational Site Maywood Illinois 60153 —
Pfizer Investigational Site Merrillville Indiana 46410 —
Pfizer Investigational Site Overland Park Kansas 66211 —
Pfizer Investigational Site Bossier City Louisiana 71111 —
Pfizer Investigational Site New Orleans Louisiana 70117-4817 —
Pfizer Investigational Site New Orleans Louisiana 70125 —
Pfizer Investigational Site Shreveport Louisiana 71101 —
Pfizer Investigational Site Shreveport Louisiana 71130 —
Pfizer Investigational Site Baltimore Maryland 21201 —
Pfizer Investigational Site Baltimore Maryland 21215 —
Pfizer Investigational Site Columbia Maryland 21045 —
Pfizer Investigational Site Randallstown Maryland 21133 —
Pfizer Investigational Site Rockville Maryland 20850 —
Pfizer Investigational Site Westminster Maryland 21157 —
Pfizer Investigational Site Brockton Massachusetts 02301 —
Pfizer Investigational Site Wellesley Hills Massachusetts 02481-2106 —
Pfizer Investigational Site Detroit Michigan 48201 —
Pfizer Investigational Site Detroit Michigan 48235 —
Pfizer Investigational Site Lansing Michigan 48917 —
Pfizer Investigational Site Livonia Michigan 48152 —
Pfizer Investigational Site Jackson Mississippi 39202 —
Pfizer Investigational Site Jackson Mississippi 39216 —
Pfizer Investigational Site Kansas City Missouri 64112 —
Pfizer Investigational Site Kansas City Missouri 64131 —
Pfizer Investigational Site St Louis Missouri 63104 —
Pfizer Investigational Site St Louis Missouri 63110 —
Pfizer Investigational Site St Louis Missouri 63141 —
Pfizer Investigational Site Cherry Hill New Jersey 08034 —
Pfizer Investigational Site East Orange New Jersey 07018 —
Pfizer Investigational Site Elizabeth New Jersey 07202 —
Pfizer Investigational Site Hammonton New Jersey 08037 —
Pfizer Investigational Site South Bound Brook New Jersey 08880 —
Pfizer Investigational Site Voorhees Township New Jersey 08043 —
Pfizer Investigational Site Woodbury New Jersey 08096 —
Pfizer Investigational Site Brooklyn New York 11203 —
Pfizer Investigational Site Brooklyn New York — —
Pfizer Investigational Site Buffalo New York 14215 —
Pfizer Investigational Site Mineola New York 11501 —
Pfizer Investigational Site Charlotte North Carolina 28209 —
Pfizer Investigational Site Greenville North Carolina 27834 —
Pfizer Investigational Site Monroe North Carolina 28112 —
Pfizer Investigational Site Monroe North Carolina — —
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Cincinnati Ohio 45219 —
Pfizer Investigational Site Cincinnati Ohio 45229 —
Pfizer Investigational Site Cincinnati Ohio 45236 —
Pfizer Investigational Site Cincinnati Ohio 45246 —
Pfizer Investigational Site Dayton Ohio 45402 —
Pfizer Investigational Site Dayton Ohio 45406 —
Pfizer Investigational Site Maumee Ohio 43537 —
Pfizer Investigational Site Perrysburg Ohio 43551 —
Pfizer Investigational Site Bensalem Pennsylvania 19020 —
Pfizer Investigational Site Philadelphia Pennsylvania 19141 —
Pfizer Investigational Site Philadelphia Pennsylvania 19146 —
Pfizer Investigational Site Philadelphia Pennsylvania 19148 —
Pfizer Investigational Site Bamberg South Carolina 29003 —
Pfizer Investigational Site Charleston South Carolina 29425 —
Pfizer Investigational Site Clinton South Carolina 29325 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Simpsonville South Carolina 29681 —
Pfizer Investigational Site Bartlett Tennessee 38134 —
Pfizer Investigational Site Jackson Tennessee 38305 —
Pfizer Investigational Site Beaumont Texas 77702 —
Pfizer Investigational Site Dallas Texas 75235 —
Pfizer Investigational Site Dallas Texas 75254 —
Pfizer Investigational Site Houston Texas 77024 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Houston Texas 77054 —
Pfizer Investigational Site Emporia Virginia 23847 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Norfolk Virginia 23510 —
Pfizer Investigational Site Richmond Virginia 23249 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Virginia Beach Virginia 23454 —
Pfizer Investigational Site Virginia Beach Virginia 23455 —
Pfizer Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00150384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2021 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00150384 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →